There was a high frequency of heart disease in Eastern European men, 27%, and women, 24%, in contrast to Canada where the frequency in women was 8%, and in men 16%.
Settling this debate once and for all will require large human trials to prove that lowering inflammation with a drug will reduce the frequency of heart attacks beyond what can be accomplished with existing classes of drugs (see: " Inflammation Is Key In Heart Attacks").